Skip to content

NMPA grants approval to felzartamab in multiple myeloma
Chemotherapy-free ATO/ATRA regimen improves survival in APL, but patient age is a crucial factor
Dr. Ying Huang presents first-in-human data for in vivo CAR-T LB2501 in B-cell NHL
Liso-cel plus ibrutinib induces deep remissions in patients with relapsed or refractory CLL/SLL
Partnership expands access to CLL treatment in low-, middle-income countries

Insider Reader Survey

Join SOHO

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Multiple Myeloma News

Cellular Therapy Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Multiple Myeloma Myelodysplastic Syndromes News

Why clinicians should lead hospitals, according to Prof. Amanda Goodall

by Leah Sherwood
March 10, 2026
0 Comments

Cellular Therapy Multiple Myeloma News

FDA accepts NDA for iberdomide in relapsed/refractory myeloma

by SOHO Insider Editors
March 9, 2026
0 Comments

Multiple Myeloma News

FDA approves teclistamab combo in relapsed myeloma

by SOHO Insider Editors
March 6, 2026
0 Comments

Multiple Myeloma

Clinical trial criteria exclude over 40% of real-world patients with AL amyloidosis

by Kerri Fitzgerald
February 19, 2026
0 Comments

Multiple Myeloma News

FDA issues draft guidance on MRD, CR endpoints in MM clinical trials

by SOHO Insider Editors
February 16, 2026
0 Comments

SOHO Asia 2026 Ambassador Program Multiple Myeloma Myelodysplastic Syndromes Myeloproliferative Neoplasms News

Yu-Hung Wang, MD, PhD, discusses unmet needs in myeloid neoplasms at SOHO Asia

by SOHO Insider Editors
February 10, 2026
0 Comments

Smoldering Multiple Myeloma Incidence Trends

Multiple Myeloma Myeloproliferative Neoplasms News

Smoldering MM trends data show increased incidence in certain patient populations

by Kerri Fitzgerald
February 3, 2026
0 Comments

Multiple Myeloma News

FDA approves daratumumab, hyaluronidase-fihj, VRd in newly diagnosed myeloma

by SOHO Insider Editors
January 29, 2026
0 Comments

Time for Phase 2. Hand holds a cube with number '2'. Word 'Phase 2'. Beautiful black background. Business concept. Copy space.

Cellular Therapy Multiple Myeloma News

Talquetamab, teclistamab combo induces responses in patients with extramedullary myeloma

by Kerri Fitzgerald
January 19, 2026
0 Comments

Multiple Myeloma News

FDA clears IND for KLN-1010 in relapsed or refractory myeloma

by SOHO Insider Editors
January 17, 2026
0 Comments

1
...
3
4
5
6
7
...
12